McCarty K S, Silva J S, Cox E B, Leight G S, Wells S A, McCarty K S
Ann Surg. 1983 Feb;197(2):123-7. doi: 10.1097/00000658-198302000-00001.
The cytosolic estrogen receptor (CER) content of 1037 primary breast carcinomas was evaluated by sucrose density gradient analysis. Tumor specimens from premenopausal patients had significantly lower levels of CER (14.6 +/- 1.5 (mean +/- SEM) 8S binding fmole/mg protein) compared with carcinomas from postmenopausal patients (57.5 +/- 3.9 fmole/mg protein; p less than 0.001). The proportion of specimens with CER levels above threshold values of 3, 7, or 10 fmoles/mg protein were significantly higher for postmenopausal patients (72%, 63%, 59%, respectively) than for premenopausal patients (56%, 42%, 36%, p less than 0.001). When compared within half-decades, no statistically significant differences between premenopausal and postmenopausal patients were observed for mean, median, or rank sums of CER levels (p greater than 0.3). When patients were compared by half-decades, both mean and ranked sums of CER levels were significantly different (p less than 0.001). The proportion of specimens that demonstrated CER levels above a threshold value of 10 fmole/mg protein increased sequentially from a low of 13/51 (26%) for patients less than 35 years to a high of 60/81 (74%) for patients greater than 75 years.
通过蔗糖密度梯度分析评估了1037例原发性乳腺癌的胞质雌激素受体(CER)含量。与绝经后患者的癌组织(57.5±3.9飞摩尔/毫克蛋白)相比,绝经前患者的肿瘤标本中CER水平显著较低(14.6±1.5(平均值±标准误)8S结合飞摩尔/毫克蛋白;p<0.001)。绝经后患者中CER水平高于3、7或10飞摩尔/毫克蛋白阈值的标本比例(分别为72%、63%、59%)显著高于绝经前患者(56%、42%、36%,p<0.001)。在按五年期进行比较时,绝经前和绝经后患者在CER水平的平均值、中位数或秩和方面未观察到统计学显著差异(p>0.3)。当按五年期对患者进行比较时,CER水平的平均值和秩和均有显著差异(p<0.001)。显示CER水平高于10飞摩尔/毫克蛋白阈值的标本比例从小于35岁患者的低水平13/51(26%)依次增加到大于75岁患者的高水平60/81(74%)。